ACTIVE

IN2PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result910 k €-7,6 %over 1 year

Gross margin2,4 M €+25,9 %over 1 year

Equity69,3 k €0,0 %over 1 year

Workforce15,1 ETP+33,6 %over 1 year

Identity

Source · BCE/KBO

IN2PHARMA is a Public limited company incorporated in 2008. Its main activity is: Management consultancy activities. Its registered office is in Kampenhout. It employs on average 15,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0895.730.662
Incorporation: 29/01/2008
Legal form: Public limited company
Registered office: Terloonststraat 22
1910 Kampenhout · FlandreSee on map
Contributed capital: 63 000,00 €
Latest accounts: 31/12/2025
Average workforce: 15,1 ETP

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74909Other professional, scientific and technical activities n.e.c.74999Other professional, scientific and technical activities n.e.c.

Joint committees (2)

200
20000

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 18 filings

Trend over 15 financial years

	2025		2024		2023		2022		2018
Income statement
Gross margin	2,4 M €	+25.9%	1,9 M €	+6.5%	1,8 M €	+21.7%	1,5 M €	+72.2%	854 k €
EBITDA	1,2 M €	+24.1%	988,2 k €	-11.4%	1,1 M €	+20.1%	928,7 k €	+219%	291,1 k €
Operating result	1,2 M €	+24.0%	987,6 k €	-11.5%	1,1 M €	+20.1%	928,7 k €	+220%	290,2 k €
Net result	910 k €	-7.6%	984,9 k €	-13.6%	1,1 M €	+21.4%	939,1 k €	+234%	281,5 k €
Balance sheet
Equity	69,3 k €	0.0%	69,3 k €	0.0%	69,3 k €	0.0%	69,3 k €	0.0%	69,3 k €
Total assets	1,5 M €	+10.8%	1,3 M €	-10.2%	1,5 M €	+24.3%	1,2 M €	+95.8%	610,2 k €
Cash	334 k €	+156%	130,7 k €	+28.9%	101,4 k €	-79.1%	484,5 k €	+92.8%	251,2 k €
Debts	1,4 M €	+11.0%	1,3 M €	-10.8%	1,4 M €	+25.8%	1,1 M €	+108%	540,9 k €
Other
Workforce	15,1 ETP	+33.6%	11,3 ETP	+31.4%	8,6 ETP	-3.4%	8,9 ETP	+30.9%	6,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Ter Loonst0536.854.616Represented by Caroline Steensels	Persoon belast met dagelijks bestuursince 13/04/2026Managing director30/06/2017 → 2021 accountsendedDirector01/02/2015 → 01/02/2021ended
Emmanuel Vanderhaegen	Directorsince 02/04/2026
Jeremy Dielen	Directorsince 02/04/2026
Patrick Van Dooren	Directorsince 02/04/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Arphius0472.247.072Represented by Swinnen Nico	Director01/02/2015 → 2021 accounts

Other companies at this address

Terloonststraat 22 1910 Kampenhout

Company	CBE no.
Arphius● Active	0472.247.072
C&N HOLDING● Active	0866.337.880
PHC Group● Active	1017.742.707
Ter Loonst● Active	0536.854.616
TT 12● Active	0832.145.083

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	10/07/2025	15/05/2024	18/07/2023	15/03/2022	06/04/2021
General meeting	17/06/2026	25/04/2025	26/04/2024	27/03/2023	28/02/2022	02/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	17/06/2026	22/06/2026	Dutch	PDF
Abridged model	31/12/2024	25/04/2025	10/07/2025	Dutch	PDF
Abridged model	31/12/2023	26/04/2024	15/05/2024	Dutch	PDF
Abridged model	31/12/2022	27/03/2023	18/07/2023	Dutch	PDF
Abridged model	31/12/2021	28/02/2022	15/03/2022	Dutch	PDF
Abridged model	31/12/2020	02/04/2021	06/04/2021	Dutch	PDF
Abridged model	31/12/2019	24/04/2020	27/04/2020	Dutch	PDF
Abridged model	31/12/2018	28/06/2019	31/07/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	31/08/2017	Dutch	PDF
Abridged model	31/12/2015	24/06/2016	28/07/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	14/08/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	31/07/2014	Dutch	PDF
Abridged model	31/12/2012	28/06/2013	25/07/2013	Dutch	PDF
Abridged model	31/12/2011	29/06/2012	23/08/2012	Dutch	PDF
Abridged model	31/12/2010	24/06/2011	03/08/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	06/08/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	18/08/2009	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Ter Loonst0536.854.616Represented by Caroline Steensels	Persoon belast met dagelijks bestuursince 13/04/2026Managing director30/06/2017 → 2021 accountsendedDirector01/02/2015 → 01/02/2021ended
Emmanuel Vanderhaegen	Directorsince 02/04/2026
Jeremy Dielen	Directorsince 02/04/2026
Patrick Van Dooren	Directorsince 02/04/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Arphius0472.247.072Represented by Swinnen Nico	Director01/02/2015 → 2021 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring11/05/2026
MET FUSIE DOOR OVERNEMING GELIJKGESTELDE VERRICHTING -
PDF
Restructuring12/02/2026
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates19/06/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/04/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/10/2017
Onslag en benoeming bestuurders
PDF
Registered office20/04/2015
MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates19/01/2015
verklaring ontslag als bestuurder
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings15 filings

Mandates

Ter Loonst

Emmanuel Vanderhaegen

Patrick Van Dooren

Jeremy Dielen

Arphius

C&N HOLDING

Orca Consulting

CAROLINE STEENSELS

NICO SWINNEN

2008200920102011201220132014201520162017201820192020202120222023202420252026

IN2PHARMA

Terloonststraat 22, 1910 Kampenhout

Managing directorDirector

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Terloonststraat 22, 1910 KampenhoutCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00182870

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
IN2PHARMACurrent	accounts 2008 → 2025	Accounts 2025 · 2026-00182870

Events

2025
Annual accounts 2025910 k €↓
2024
Annual accounts 2024984,9 k €↓
2023
Annual accounts 20231,1 M €↑
2022
Annual accounts 2022939,1 k €↑
2018
Annual accounts 2018281,5 k €↑
2017
Annual accounts 201793,3 k €↓
2016
Annual accounts 2016123,8 k €↑
2015
Annual accounts 2015107,6 k €↑
2014
Annual accounts 201429,3 k €↑
2013
Annual accounts 201327,2 k €↓
2012
Annual accounts 201278,2 k €↑
2011
Annual accounts 201125,7 k €↓
2010
Annual accounts 2010104,6 k €↑
2009
Annual accounts 200940,2 k €↓
2008
Annual accounts 200851,1 k €
29/01/2008
IncorporationPublic limited company

IN2PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events